Aardvark Therapeutics已决定暂停其Ard-201肥胖症治疗项目的研发进程,该项目原计划包含针对患者力量与体能改善的临床试验。公司表示,关于该项目的后续发展方向及详细计划,预计将在2026年第二季度提供进一步的明确指引。
Aardvark Therapeutics已决定暂停其Ard-201肥胖症治疗项目的研发进程,该项目原计划包含针对患者力量与体能改善的临床试验。公司表示,关于该项目的后续发展方向及详细计划,预计将在2026年第二季度提供进一步的明确指引。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.